Neuropsychopharmacology
- Fueling the future: brain bioenergetics as a driver of neurodevelopment and mental health trajectories8 months ago
- Clozapine induces perineuronal net remodeling in a developmental mouse model exhibiting schizophrenia-relevant phenotypes8 months ago
- Change in brain molecular landscapes following electrical stimulation of the nucleus accumbens8 months ago
- Acute effects of MDMA, MDA, lysine-MDMA, and lysine-MDA in a randomized, double-blind, placebo-controlled, crossover trial in healthy participants8 months ago
- Cannabinoid CB1 receptor and mu-opioid receptor interaction: new insights from conditional knockout mice8 months ago
- Concerted elevations of cortical and striatal glutamate and GABA in antipsychotic-free individuals at clinical high-risk for psychosis8 months ago
- Reversible modulation of a deep white matter surgical target for depression with low-intensity focused ultrasound8 months ago
Journal of Psychopharmacology
- Lifetime classic psychedelic use and headaches: A cross-sectional study1 year ago
- A three-stage strategy for conducting an experimental investigation: A recommendation to improve the reproducibility of reported conclusions1 year ago
- Single-dose psilocybin therapy for alcohol use disorder: Pharmacokinetics, feasibility, safety and efficacy in an open-label study1 year ago
- Acute subanesthetic ketamine-induced effects on the mismatch negativity and their relationship to early and sustained treatment response in major depressive disorder1 year ago
- Quantitative natural language processing markers of psychoactive drug effects: A pre-registered systematic review1 year ago
- Recasting the role of electroconvulsive therapy and the electroconvulsive therapy practitioner: For severe illness, not necessarily treatment-resistant depression1 year ago
- The mechanism of action of clozapine1 year ago
European Neuropsychopharmacology
- Disease continuum centered on Parkinson’s disease1 year ago
- Low dose oral ketamine treatment on post-traumatic stress disorder (PTSD) (OKTOP): An open-label pilot study1 year ago
- Preliminary evidence should be treated as such: Response to “Is creatine useful as adjuvant in cognitive-behavioural therapy for depression?”1 year ago
- A specific GPR56/ADGRG1 splicing isoform is associated with antidepressant response in major depressive disorder1 year ago
- Classical psychedelics in therapy: Essential psychotherapy or minimal support?1 year ago
- Differential effects of Xanomeline-trospium chloride on positive and negative symptoms in Schizophrenia: The role of dose1 year ago
- MiRNAs and extracellular vesicles in psychiatry: Potential biomarkers, therapeutic advances, and animal models1 year ago